Known targets — ChEMBL curated mechanism
ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRAP1 | Q12931 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | SMYD2 | Q9NRG4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11934183 | 0.81 | SMYD2 (0.35) | CYP3A4HTTSMN1; SMN2SMYD2 | |
| Bromide SCHEMBL10011564 | 0.79 | SNCA (0.44) | CYP3A4HTTSMN1; SMN2SMYD2 | |
| Hydrochloric Acid SCHEMBL9292718 | 0.74 | HIF1A (0.44) | TRAP1HTTSMN1; SMN2 | |
| SCHEMBL17159412 | 0.74 | LMNA (0.37) | HTTSMN1; SMN2 | |
| SCHEMBL6132650 | 0.74 | KDM5A (0.36) | CYP3A4SMN1; SMN2SMYD2 | |
| SCHEMBL30516569 | 0.74 | KDM5A (0.36) | CYP3A4SMN1; SMN2SMYD2 | |
| SCHEMBL1586886 | 0.72 | SMYD2 (0.33) | CYP3A4HTTSMN1; SMN2SMYD2 | |
| SCHEMBL1587700 | 0.72 | KDR (0.33) | CYP3A4SMYD2 | |
| SCHEMBL1587497 | 0.71 | SMYD2 (0.34) | HTTSMN1; SMN2SMYD2 | |
| Bromide SCHEMBL7471956 | 0.70 | CHRNA7 (0.40) | TRAP1CYP3A4HTTSMN1; SMN2SMYD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10754064-B2 | Second-order nonlinear optical compound and nonlinear optical element comprising the same | NATIONAL INSTITUTE OF INFORMATION AND COMMUNICATIONS TECHNOLOGY (JP) | 2020-08-25 | — | — | US | disclosed |
| US-20180224577-A1 | SECOND-ORDER NONLINEAR OPTICAL COMPOUND AND NONLINEAR OPTICAL ELEMENT COMPRISING THE SAME | NATIONAL INSTITUTE OF INFORMATION AND COMMUNICATIONS TECHNOLOGY (JP) | 2018-08-09 | — | — | US | disclosed |
| US-9977150-B2 | Second-order nonlinear optical compound and nonlinear optical element comprising the same | NATIONAL INSTITUTE OF INFORMATION AND COMMUNICATIONS TECHNOLOGY (JP) | 2018-05-22 | — | — | US | disclosed |
| US-9488755-B2 | Second-order nonlinear optical compound and nonlinear optical element comprising the same | NATIONAL INSTITUTE OF INFORMATION AND COMMUNICATIONS TECHNOLOGY (JP) | 2016-11-08 | — | — | US | disclosed |
| US-20160318889-A1 | SECOND-ORDER NONLINEAR OPTICAL COMPOUND AND NONLINEAR OPTICAL ELEMENT COMPRISING THE SAME | NAT INST INF & COMM TECH (JP) | 2016-11-03 | — | — | US | disclosed |
| US-20150048284-A1 | SECOND-ORDER NONLINEAR OPTICAL COMPOUND AND NONLINEAR OPTICAL ELEMENT COMPRISING THE SAME | NAT INST INF & COMM TECH (JP) | 2015-02-19 | — | — | US | disclosed |
| US-8846955-B2 | Second-order nonlinear optical compound and nonlinear optical element comprising the same | NATIONAL INSTITUTE OF INFORMATION AND COMMUNICATIONS TECHNOLOGY (JP) | 2014-09-30 | — | — | US | disclosed |
| US-20120172599-A1 | SECOND-ORDER NONLINEAR OPTICAL COMPOUND AND NONLINEAR OPTICAL ELEMENT COMPRISING THE SAME | SUMITOMO ELECTRIC INDUSTRIES, LTD. (JP) | 2012-07-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160318889-A1 | SECOND-ORDER NONLINEAR OPTICAL COMPOUND AND NONLINEAR OPTICAL ELEMENT COMPRISING THE SAME | OGFOD1, OCIAD2, OCIAD1 | TRAP1 4868/4885CYP3A4 864/4885HTT 3353/4885 |
| US-20150048284-A1 | SECOND-ORDER NONLINEAR OPTICAL COMPOUND AND NONLINEAR OPTICAL ELEMENT COMPRISING THE SAME | OGFOD1, OCIAD2, OCIAD1 | TRAP1 4868/4885CYP3A4 864/4885HTT 3353/4885 |
| US-10754064-B2 | Second-order nonlinear optical compound and nonlinear optical element comprising the same | OGFOD1, OCIAD2, OCIAD1 | TRAP1 4868/4885CYP3A4 864/4885HTT 3353/4885 |
| US-20180224577-A1 | SECOND-ORDER NONLINEAR OPTICAL COMPOUND AND NONLINEAR OPTICAL ELEMENT COMPRISING THE SAME | OGFOD1, OCIAD2, OCIAD1 | TRAP1 4868/4885CYP3A4 864/4885HTT 3353/4885 |
| US-20120172599-A1 | SECOND-ORDER NONLINEAR OPTICAL COMPOUND AND NONLINEAR OPTICAL ELEMENT COMPRISING THE SAME | OGFOD1, OCIAD2, OCIAD1 | TRAP1 4868/4885CYP3A4 864/4885HTT 3353/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.